GSK Files Its BCMA Drug In Multiple Myeloma

Filing Underpinned By Good DREAMM-2 results

 
• By Sten Stovall
  
Multiple_Myeloma
GSK’s Could Become First Anti-BCMA Agent Approved In US • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip